Nivolumab for relapsed or refractory <scp>H</scp>odgkin lymphoma: Experience in <scp>T</scp>urkey

Medicine, Nivolumab, Brentuximab vedotin, Refractory (planetary science), Internal medicine, Radiological weapon, Surgery, Oncology, Lymphoma, Hodgkin lymphoma, Immunotherapy, Cancer